Trial intelligence / Profile preview

Dexmedetomidine vs Midazolam with Ketamine for Sedation in Pediatric BMA

NCT03647579Completed

Sponsor
Assiut University
Start
Aug 2018
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of dexmedetomidine in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Assiut University. Primary endpoint: Ramsay sedation score. Started Aug 2018; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

acute lymphoblastic leukemia (ALL)

Beyond the preview

Go deeper on NCT03647579.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03647579.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call